Eurobio Scientific (XPAR:ALERS) ROCE % : 4.64% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Eurobio Scientific ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Eurobio Scientific's annualized ROCE % for the quarter that ended in Dec. 2023 was 4.64%.

Eurobio Scientific ROCE % Historical Data

The historical data trend for Eurobio Scientific's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurobio Scientific ROCE % Chart

Eurobio Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

1.85

93.93

48.13

13.84

4.22

Eurobio Scientific Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															41.00	25.50	7.47	3.80	4.64

Eurobio Scientific ROCE % Calculation

Eurobio Scientific's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	11.334	/	( ( (330.731 - 57.316)	+	(316.329 - 52.878) )	/ 2 )
	=	11.334	/	( (273.415	+	263.451)	/ 2 )
	=	11.334	/	268.433
	=	4.22 %

Eurobio Scientific's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	12.37	/	( ( (313.179 - 43.962)	+	(316.329 - 52.878) )	/ 2 )
	=	12.37	/	( ( 269.217	+	263.451 )	/ 2 )
	=	12.37	/	266.334
	=	4.64 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Eurobio Scientific (XPAR:ALERS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Eurobio Scientific ROCE % Related Terms

Thank you for viewing the detailed overview of Eurobio Scientific's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Eurobio Scientific (XPAR:ALERS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eurobio Scientific (XPAR:ALERS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

E8TN:Germany

Address

63-65 Boulevard Massena, Paris, FRA, 75013

Website

http://www.exonhit.com

Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.

Eurobio Scientific (XPAR:ALERS) Headlines

No Headlines